Patent & IP news for March 6, 2018

Patent Litigations

  • No new litigations this day!

USPTO Weekly Stats

9,071
published
appl'ns
6,867
granted
patents
64
ptab
decisions

Patent & IP Blogs

News from Abroad -- Australia Remains a Gene-Patent Friendly Jurisdiction from www.patentdocs.org

By Grant Shoebridge* -- When the Australian High Court ruled against the patentability of isolated naturally occurring genes in the Myriad decision, a number of commentators believed that the decision would ultimately invalidate claims directed to ...

Share via E–mail | Twitter | Facebook

Appellant Nalco wins reversal at CAFC: The “purpose of a motion to dismiss is to test the sufficiency of the complaint, not to decide the merits.” from ipbiz.blogspot.com


The outcome:



Nalco Company (“Nalco”) appeals from the district
court’s decision dismissing its Fourth Amended Complaint
(“4AC”) with prejudice for failure to state a claim
upon which relief can be granted. The 4AC alleged ...

Share via E–mail | Twitter | Facebook

Knowles loses appeal at CAFC from ipbiz.blogspot.com




Appellant Knowles Electronics, LLC (“Knowles”) appeals
the inter partes reexamination decision on appeal of
the U.S. Patent and Trademark Office’s (“USPTO”) Patent
Trial and Appeal Board (“PTAB”) affirming an examiner’s
rejection of ...

Share via E–mail | Twitter | Facebook

Inside Views: Early Certainty Initiative Of The European Patent Office – Flexibility For Biotech Needed from www.ip-watch.org

In 2016, the European Patent Office (EPO) introduced a streamlined opposition procedure that should simplify opposition proceedings and deliver decisions faster, while giving parties more time to react to summons and prepare for oral proceedings ...

Share via E–mail | Twitter | Facebook

Pharma, Nonprofits Collaborate On Affordable Hepatitis C Treatment In Latin America from www.ip-watch.org

The Drugs for Neglected Disease initiative (DNDi), a nonprofit research and development organisation, today announced a collaboration with pharmaceutical companies to manufacture and supply a "new, more affordable" hepatitis C treatment in Latin America. Hepatitis ...

Share via E–mail | Twitter | Facebook

CBM Estoppel Does Not Apply to Entire Statutory Provision, But to Discrete Prior Art References or Combinations from docketreport.blogspot.com

The court denied plaintiff's motion in limine to exclude evidence of obviousness because CBM estoppel did not apply to an entire statutory basis. "Plaintiff argues that, because [defendant's] CBM challenge was based on ...

Share via E–mail | Twitter | Facebook

Investor Protection Clauses In Bilateral Trade Agreements Take A Hit In EU from www.ip-watch.org

Investor protection clauses in bilateral trade agreements between European Union member states were declared incompatible with EU law in a judgment by the European Court of Justice in Luxembourg today.

Share via E–mail | Twitter | Facebook

The Quest to Patent Perpetual Motion from writtendescription.blogspot.com

Those familiar with my work will know that I am a big fan of utility doctrine. I think it is underused and misunderstood. When I teach about operable utility, I use perpetual motion machines as ...

Share via E–mail | Twitter | Facebook

Haptic Feedback Patents: Some Survive Eligibility Challenge by Fitbit from patentlyo.com

Immersion Corp. v. Fitbit (N.D.Cal. March 5, 2018) On 12(b)(6) motion for dismiss, Judge Koh has thrown out some of Immersion’s asserted claims covering various haptic feedback approaches. However, some ...

Share via E–mail | Twitter | Facebook

Some content © 2007–2018 RPX Corporation.
Terms of Service & Privacy Policy
For DMCA requests contact help@priorsmart.com.